Abeona Therapeutics (ABEO) Total Debt (2010 - 2026)

Abeona Therapeutics' Total Debt history runs 13 years deep, the most recent figure standing at $18.1 million for Q1 2026.

• In Q1 2026, Total Debt fell 6.22% year-over-year to $18.1 million; the TTM figure through Mar 2026 stood at $18.1 million (down 6.22% YoY), while the FY2025 annual figure was $20.0 million, up 5.65% from the prior year.
• Total Debt was $18.1 million for Q1 2026 at Abeona Therapeutics, down from $20.0 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $20.0 million in Q4 2025 to a low of $4.2 million in Q4 2022.
• Historically, Total Debt has averaged $15.5 million across 4 years, with a median of $18.4 million in 2024.
• Biggest YoY gain for Total Debt was 402.22% in 2022; the steepest drop was 68.32% in 2022.
• A 4-year view of Total Debt shows it stood at $4.2 million in 2022, then surged by 355.51% to $19.0 million in 2024, then gained by 5.65% to $20.0 million in 2025, then declined by 9.72% to $18.1 million in 2026.
• The last three Total Debt figures came in at $18.1 million (Q1 2026), $20.0 million (Q4 2025), and $19.8 million (Q3 2025), per Business Quant data.